ArticlePloS one2025
Modeling the spectrum and determinants of multimorbidity risk among older adults in India.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prevalence and predictors of self-reported multimorbidity and locomotor disability among the geriatric population in coastal South Karnataka, India.BMC geriatrics · 2026Article
- Article
- Outliving and outlasting: explaining sex inequities in healthy life expectancy through the lens of multimorbidity and within morbidities in older populations in India.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndia is passing through a parallel phase of demographic and epidemiological transition coupled with the shifting burden of multimorbidity. Unhealthy ageing and escalating morbidity burden have been identified as key drivers of this shifting multimorbidity risk among older adults in India. This study aims to assess the distribution of morbidities and multimorbidity, provide new estimates of multimorbidity risk by socio-economic and demographic factors and further evaluate the multimorbidity count risk conditioned on leading factors.
methodsThis study used the nationally representative Longitudinal Ageing Study in India (LASI), Wave - 1, 2017-18, data of individuals aged 45 years and above. First, we assessed the relative proportional share of morbidities and compositions of multimorbidity counts over age. Second, we applied the Random Forest (RF) model to estimate the age-specific risk of multimorbidity susceptibility associated with socio-economic and demographic factors over age. Finally, conditional plots were constructed to assess the distributional composition of the leading factors affecting multimorbidity counts.
resultsThe prevalence of multimorbidity was 43.20%. Eye disorders, followed by cardiovascular disease (CVDs), had the highest proportional share over age. Endocrine diseases, Gastrointestinal Conditions, and Infectious diseases showed a concordant decreasing proportional share in later age. The relative share of five or more multimorbidity counts increased significantly with age. The median expected risk of multimorbidity was significantly higher in females (66 years) than in males (71 years). The study also provides empirical evidence that individuals with higher levels of education, obesity, currently working, and poor childhood health were more prone to higher risk of multimorbidity at an early age. Furthermore, obesity was significantly associated with early multimorbidity onset and led to a pronounced escalation of complex multimorbidity progression, particularly in females.
conclusionsCollective public health interventions are crucial to address early multimorbidity onset and burden disparities, to promote healthier ageing, and to address etiological factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.